The U.S. Food and Drug Administration recently approved Ascelera (polidocanol) injections for the treatment of small varicose veins. Asclera has been approved to close spider veins, which are very small veins less than 1 millimeter in diameter, and reticular veins, which are 1-3 millimeters in diameter.Polidocanol creates fibrosis, (the development of excess connective tissue in an organ or tissue as a reparative process), within the cell lining of blood vessels. This causes them to collapse, and eventually, the vein is then replaced by other types of tissue.
Adverse reactions to the drug include leakage, hematoma, bruising, irritation, discoloration, and pain at the injection site. Drug administration should always be performed by a professional varicose vein treatment specialist, preferably a licensed and certified physician.'Varicose veins are a common condition,' said Norman Stockbridge, M.D., Ph.D., director of the Division of Cardiovascular and Renal Products at the FDA\'s Center for Drug Evaluation and Research. 'Asclera is indicated for the treatment of small types of varicose veins when the aim of treatment is to improve appearance.'
Varicose veins are swollen or abnormally twisted blood vessels that usually form in the legs, but they can also form in other places, such as the face.Spider veins are considered cosmetic and most insurance carriers do not cover their treatment. Nevertheless, spider veins also may cause symptoms, including aching, throbbing, and itchy legs.
Heredity, age, and living in the western world are all known contributors to varicose veins. Women, especially if previously pregnant, are more likely to develop varicose veins.
FDA press release.
Article Source: http://www.articlesbase.com
About the Author
One of very few full-time vein clinics, Novi Vein has established itself as Metro Detroit\'s premier medical office for the treatment of varicose veins and spider veins. Utilizing state-of-the-art technology in a world-class medical facility, Novi Vein offers the latest in medical care for the vein patient.
Adverse reactions to the drug include leakage, hematoma, bruising, irritation, discoloration, and pain at the injection site. Drug administration should always be performed by a professional varicose vein treatment specialist, preferably a licensed and certified physician.'Varicose veins are a common condition,' said Norman Stockbridge, M.D., Ph.D., director of the Division of Cardiovascular and Renal Products at the FDA\'s Center for Drug Evaluation and Research. 'Asclera is indicated for the treatment of small types of varicose veins when the aim of treatment is to improve appearance.'
Varicose veins are swollen or abnormally twisted blood vessels that usually form in the legs, but they can also form in other places, such as the face.Spider veins are considered cosmetic and most insurance carriers do not cover their treatment. Nevertheless, spider veins also may cause symptoms, including aching, throbbing, and itchy legs.
Heredity, age, and living in the western world are all known contributors to varicose veins. Women, especially if previously pregnant, are more likely to develop varicose veins.
FDA press release.
Article Source: http://www.articlesbase.com
About the Author
One of very few full-time vein clinics, Novi Vein has established itself as Metro Detroit\'s premier medical office for the treatment of varicose veins and spider veins. Utilizing state-of-the-art technology in a world-class medical facility, Novi Vein offers the latest in medical care for the vein patient.